{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:25:57Z","timestamp":1783531557706,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13300-025-01764-1","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:37:25Z","timestamp":1751549845000},"page":"1797-1811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes"],"prefix":"10.1007","volume":"16","author":[{"given":"Khandhulwa Chandramouli","family":"Bhuvanesswar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijendra Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandakumar","family":"Amutha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillips","family":"Routray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanasekaran","family":"Killivalavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Jebarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulagamathesan","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosette James","family":"Chakkalakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janardanan Subramonia","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duvvur","family":"Nageshwar Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit Mohan","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Govindarajapuram","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-6210","authenticated-orcid":false,"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"1764_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","volume":"11","author":"RM Anjana","year":"2023","unstructured":"Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, et\u00a0al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11:474\u201389.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1764_CR2","first-page":"1","volume":"22","author":"V Mohan","year":"2009","unstructured":"Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Adm. 2009;22:1\u201318.","journal-title":"Health Adm"},{"key":"1764_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2337\/db16-0766","volume":"66","author":"R Unnikrishnan","year":"2017","unstructured":"Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 diabetes: demystifying the global epidemic. Diabetes. 2017;66:1432\u201342.","journal-title":"Diabetes"},{"key":"1764_CR4","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","volume":"54","author":"RM Anjana","year":"2011","unstructured":"Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et\u00a0al. Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research\u2013INdia DIABetes (ICMR\u2013INDIAB) study. Diabetologia. 2011;54:3022\u20137.","journal-title":"Diabetologia"},{"key":"1764_CR5","first-page":"152","volume":"56","author":"V Mohan","year":"2008","unstructured":"Mohan V, Deepa M, Anjana RM, Lanthorn H, Deepa R. Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19). J Assoc Physicians India. 2008;56:152\u20137.","journal-title":"J Assoc Physicians India"},{"key":"1764_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1464-5491.2005.01616.x","volume":"22","author":"V Mohan","year":"2005","unstructured":"Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease\u2013The Chennai Urban Population Study (CUPS no. 15). Diabet Med J Br Diabet Assoc. 2005;22:1206\u201311.","journal-title":"Diabet Med J Br Diabet Assoc."},{"key":"1764_CR7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et\u00a0al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19-40.","journal-title":"Diabetes Care"},{"key":"1764_CR8","unstructured":"IDF Diabetes Atlas 2021 | IDF Diabetes Atlas. Available from: https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/"},{"key":"1764_CR9","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492\u2013542."},{"key":"1764_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, et\u00a0al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72:2138\u201348.","journal-title":"Gut"},{"key":"1764_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000904","volume":"8","author":"S Ciardullo","year":"2020","unstructured":"Ciardullo S, Muraca E, Perra S, Bianconi E, Zerbini F, Oltolini A, et\u00a0al. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. 2020;8: e000904.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1764_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/VHRM.S1991","volume":"4","author":"CR Ban","year":"2008","unstructured":"Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag. 2008;4:575\u201396.","journal-title":"Vasc Health Risk Manag"},{"key":"1764_CR13","doi-asserted-by":"publisher","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","volume":"304","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg M, Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol - Cell Physiol. 2013;304:C216\u201325.","journal-title":"Am J Physiol - Cell Physiol"},{"key":"1764_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, et\u00a0al. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022;12:818\u201329.","journal-title":"J Clin Exp Hepatol"},{"key":"1764_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","volume":"84","author":"V Mohan","year":"2009","unstructured":"Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009;84:84\u201391.","journal-title":"Diabetes Res Clin Pract"},{"key":"1764_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2023.100161","volume":"12","author":"A Sinha","year":"2023","unstructured":"Sinha A, Bankura B. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India. Diabetes Epidemiol Manag. 2023;12: 100161.","journal-title":"Diabetes Epidemiol Manag"},{"key":"1764_CR17","first-page":"385","volume":"28","author":"R Deb","year":"2024","unstructured":"Deb R, Goswami S, Sengupta N, Baidya A, Khare VR, Datta J, et\u00a0al. Prevalence of clinically significant liver fibrosis as measured by transient elastography due to non-alcoholic fatty liver disease in Indian individuals with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2024;28:385\u201390.","journal-title":"Indian J Endocrinol Metab"},{"key":"1764_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/jdi.13411","volume":"12","author":"S Kubihal","year":"2021","unstructured":"Kubihal S, Gupta Y, Shalimar, Kandasamy D, Goyal A, Kalaivani M, et\u00a0al. Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. J Diabetes Investig. 2021;12:877\u201385.","journal-title":"J Diabetes Investig"},{"key":"1764_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.59556\/japi.72.0582","volume":"72","author":"V Panikar","year":"2024","unstructured":"Panikar V, Gupta A, Nasikkar N, Joshi S, Walwalkar S, Sachdev I, et\u00a0al. Prevalence and association of risk factors according to liver steatosis and fibrosis stages among nonalcoholic fatty liver disease patients with type 2 diabetes mellitus in India: a cross-sectional study. J Assoc Physicians India. 2024;72:29\u201333.","journal-title":"J Assoc Physicians India"},{"key":"1764_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et\u00a0al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"1764_CR21","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/v15081730","volume":"15","author":"L Rinaldi","year":"2023","unstructured":"Rinaldi L, Giorgione C, Mormone A, Esposito F, Rinaldi M, Berretta M, et\u00a0al. Non-invasive measurement of hepatic fibrosis by transient elastography: a narrative review. Viruses. 2023;15:1730.","journal-title":"Viruses"},{"key":"1764_CR22","first-page":"605","volume":"8","author":"NH Afdhal","year":"2012","unstructured":"Afdhal NH. Fibroscan (transient elastography) for the measurement of liver fibrosis. Gastroenterol Hepatol. 2012;8:605\u20137.","journal-title":"Gastroenterol Hepatol"},{"key":"1764_CR23","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et\u00a0al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717\u201330.","journal-title":"Gastroenterology"},{"key":"1764_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","volume":"36","author":"M Sasso","year":"2012","unstructured":"Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13\u201320.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1764_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med J Br Diabet Assoc. 1998;15:539\u201353.","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"1764_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2016.11.006","volume":"123","author":"A Amutha","year":"2017","unstructured":"Amutha A, Anjana RM, Venkatesan U, Ranjani H, Unnikrishnan R, Narayan KMV, et\u00a0al. Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract. 2017;123:1\u20138.","journal-title":"Diabetes Res Clin Pract"},{"key":"1764_CR27","unstructured":"The Asia-Pacific perspective\u202f: redefining obesity and its treatment. Available from: https:\/\/iris.who.int\/handle\/10665\/206936"},{"key":"1764_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome\u2014A new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469\u201380.","journal-title":"Diabet Med"},{"key":"1764_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et\u00a0al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatol Baltim Md. 2006;43:1317\u201325.","journal-title":"Hepatol Baltim Md"},{"key":"1764_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et\u00a0al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatol Baltim Md. 2007;45:846\u201354.","journal-title":"Hepatol Baltim Md"},{"key":"1764_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C-T Wai","year":"2003","unstructured":"Wai C-T, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et\u00a0al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol Baltim Md. 2003;38:518\u201326.","journal-title":"Hepatol Baltim Md"},{"key":"1764_CR32","first-page":"122","volume":"20","author":"DA Khan","year":"2008","unstructured":"Khan DA, Fatima-Tuz-Zuhra, Khan FA, Mubarak A. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients. J Ayub Med Coll Abbottabad JAMC. 2008;20:122\u20136.","journal-title":"J Ayub Med Coll Abbottabad JAMC."},{"key":"1764_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"Z-H Lin","year":"2011","unstructured":"Lin Z-H, Xin Y-N, Dong Q-J, Wang Q, Jiang X-J, Zhan S-H, et\u00a0al. Performance of the aspartate aminotransferase\u2013to\u2013platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatol Baltim Md. 2011;53:726\u201336.","journal-title":"Hepatol Baltim Md"},{"key":"1764_CR34","first-page":"915","volume":"5","author":"MS Kuchay","year":"2021","unstructured":"Kuchay MS, Choudhary NS, Mishra SK, Bano T, Gagneja S, Mathew A, et\u00a0al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. JGH Open Open Access J Gastroenterol Hepatol. 2021;5:915\u201322.","journal-title":"JGH Open Open Access J Gastroenterol Hepatol"},{"key":"1764_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101553","volume":"51","author":"A Ramakrishnan","year":"2022","unstructured":"Ramakrishnan A, Velmurugan G, Somasundaram A, Mohanraj S, Vasudevan D, Vijayaragavan P, et\u00a0al. Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: a cross-sectional study. eClinicalMedicine. 2022;51: 101553.","journal-title":"eClinicalMedicine."},{"key":"1764_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et\u00a0al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793\u2013801.","journal-title":"J Hepatol"},{"key":"1764_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cgh.2018.08.069","volume":"17","author":"F Bazerbachi","year":"2019","unstructured":"Bazerbachi F, Haffar S, Wang Z, Cabezas J, Arias-Loste MT, Crespo J, et\u00a0al. Range of normal liver stiffness and factors associated with increased stiffness measurements in apparently healthy individuals. Clin Gastroenterol Hepatol. 2019;17:54-64.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1764_CR38","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/liv.15053","volume":"41","author":"O Danielsson","year":"2021","unstructured":"Danielsson O, Nissinen MJ, Jula A, Salomaa V, M\u00e4nnist\u00f6 S, Lundqvist A, et\u00a0al. Waist and hip circumference are independently associated with the risk of liver disease in population-based studies. Liver Int. 2021;41:2903\u201313.","journal-title":"Liver Int"},{"key":"1764_CR39","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/gut.2007.142919","volume":"57","author":"M Manco","year":"2008","unstructured":"Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, et\u00a0al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut. 2008;57:1283\u20137.","journal-title":"Gut"},{"issue":"2","key":"1764_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108910","volume":"39","author":"AA Alfadda","year":"2024","unstructured":"Alfadda AA, Alqutub AN, Sherbeeni SM, Aldosary AS, Alqahtani SA, Isnani A, et\u00a0al. Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD. J Diabetes Complic. 2024;39(2): 108910.","journal-title":"J Diabetes Complic"},{"key":"1764_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.orcp.2023.09.005","volume":"17","author":"J-H Lee","year":"2023","unstructured":"Lee J-H, Jeon S, Lee HS, Kwon Y-J. Association between waist circumference trajectories and incident non-alcoholic fatty liver disease. Obes Res Clin Pract. 2023;17:398\u2013404.","journal-title":"Obes Res Clin Pract"},{"key":"1764_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12916-024-03779-0","volume":"22","author":"P Mishra","year":"2024","unstructured":"Mishra P, Sadananthan SA, Yaligar J, Tan KH, Chong YS, Gluckman PD, et\u00a0al. Even moderate liver fat accumulation below conventional fatty liver cutoffs is linked to multiple metabolomic alterations and gestational dysglycemia in Asian women of reproductive age. BMC Med. 2024;22:561.","journal-title":"BMC Med"},{"key":"1764_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003193","volume":"95","author":"P-N Cheng","year":"2016","unstructured":"Cheng P-N, Chiu Y-C, Chiu H-C, Chien S-C. The application of liver stiffness measurement in residents without overt liver diseases through a community-based screening program. Medicine (Baltimore). 2016;95: e3193.","journal-title":"Medicine (Baltimore)"},{"key":"1764_CR44","first-page":"57","volume":"18","author":"R Sirli","year":"2009","unstructured":"Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis JGLD. 2009;18:57\u201360.","journal-title":"J Gastrointest Liver Dis JGLD"},{"key":"1764_CR45","first-page":"1357","volume":"48","author":"F Conti","year":"2016","unstructured":"Conti F, Vukotic R, Foschi FG, Domenicali M, Giacomoni P, Savini S, et\u00a0al. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: an Italian community-based population study. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2016;48:1357\u201363.","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"1764_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.31729\/jnma.2189","volume":"52","author":"BK Basnet","year":"2014","unstructured":"Basnet BK, Kc S, Sharma D, Shrestha D. Transient elastographic values of healthy volunteers in a tertiary care hospital. JNMA J Nepal Med Assoc. 2014;52:661\u20137.","journal-title":"JNMA J Nepal Med Assoc"},{"key":"1764_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clnesp.2021.08.028","volume":"46","author":"A Gupta","year":"2021","unstructured":"Gupta A, Anoop S, Ansari IA, Prakash S, Misra A. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. Clin Nutr ESPEN. 2021;46:519\u201326.","journal-title":"Clin Nutr ESPEN"},{"key":"1764_CR48","first-page":"61","volume":"19","author":"M Balakrishnan","year":"2021","unstructured":"Balakrishnan M, Patel P, Dunn-Valadez S, Dao C, Khan V, Ali H, et\u00a0al. Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19:61-71.e15.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"1764_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13244-024-01857-8","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Huang Y, Zhang Y, Zhou D, Yang Y, Zhang S, et\u00a0al. Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B. Insights Imaging. 2024;15:283.","journal-title":"Insights Imaging"},{"key":"1764_CR50","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/gut.2007.126417","volume":"56","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, et\u00a0al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330\u20131.","journal-title":"Gut"},{"key":"1764_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, et\u00a0al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41:261\u201370.","journal-title":"Liver Int"},{"key":"1764_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202393","volume":"13","author":"N Peleg","year":"2018","unstructured":"Peleg N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, Braun M, Shlomai A. Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease. PLoS\u00a0One. 2018;13: e0202393.","journal-title":"PLoS\u00a0One"},{"key":"1764_CR53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3350\/cmh.2019.0001n","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wong GL-H, Wong VW-S. Application of transient elastography in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:128\u201341.","journal-title":"Clin Mol Hepatol"},{"key":"1764_CR54","first-page":"31","volume":"11","author":"A Deleanu","year":"2009","unstructured":"Deleanu A, Sirli R, Popescu A, Sporea I. Feasability, accuracy and reproducibility of transient elastography. Med Ultrason. 2009;11:31\u20135.","journal-title":"Med Ultrason"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01764-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:09:13Z","timestamp":1756897753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01764-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01764-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kandhulwa Chandramouli Bhuvanesswar, Brijendra Kumar Srivastava, Anandakumar Amutha, Varun Damle, Aswin Krishna, Prasanna Kumar Gupta, Phillips Routray, Dhanasekaran Killivalavan, Saravanan Jebarani, Ulagamathesan Venkatesan, Rosette James Chakkalakal, Shalimar, Janardanan Subramonia Kumar, Duvvur Nageshwar Reddy, Anand V Kulkarni, Ranjit Unnikrishnan, Ranjit Mohan Anjana, Krishna Govindarajapuram Seshadri, and Viswanathan Mohan have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Institutional Ethics Committee of the Madras Diabetes Research Foundation has waived the requirement for ethical clearance for this study for both the sites (MDRF\/NCT\/06\/01\/2024; dated 28\/06\/2024). We also confirm that the study was performed in accordance with the Declaration of Helsinki of 1964, and its later amendments and as per the Indian Council of Medical Research (ICMR) Ethical guidelines. All participants provided written informed consent to use their deidentified clinical data anonymously for analysis and scientific research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}